topa-slice

Directors

jayT

Jay A. Tischfield

Founder, Chief Executive Officer and Scientific Director

As Founder, CEO and Scientific Director, Dr. Jay A. Tischfield is responsible for the scientific direction, funding and overall mission of RUCDR Infinite Biologics. His over 200 publications describe the genetics of severe combined

Click to read more or click to close

immunodeficiency disease,inherited kidney stone diseases, alcoholism, limb-girdle muscular dystrophy, autism and Tourette syndrome, as well as basic science related to our understanding of genetic stability in somatic and pluripotent stem cells. His experience in organizing, leading and executing large scale projects involving hundreds of thousands of human subjects provides the background expertise for RUCDR Infinite Biologics. Jay is among the top five percent of National Institutes of Health-funded researchers for over 35 years, with over $250 million in total funding.

Jay has current certification in two Medical Genetics sub-specialties and is a Founding Fellow of the American College of Medical Genetics. He received the Distinguished Alumnus medal from Brooklyn College and was elected a Fellow of the American Association for the Advancement of Science. He served as a biomedical infrastructure advisor to Singapore for nearly two decades. He has held professorial appointments at five U.S. Schools of Medicine and is currently MacMillan Professor II at Rutgers University, Professor of Pediatrics and Psychiatry at Robert Wood Johnson Medical School and Director of the Human Genetics Institute of New Jersey. He received his M.Phil. and Ph.D. degrees from Yale and did a postdoctoral fellowship in Pediatrics at the University of California, San Francisco.

andyBrooks

Andrew I. Brooks

Chief Operating Officer and Director of Technology Development

As the Chief Operating Officer of RUCDR Infinite Biologics, Dr. Andrew Brooks oversees the operations of all laboratories within RUCDR, ensuring consistent and superior quality standards for all services.

Click to read more or click to close

Since joining RUCDR, he has worked to automate and develop the service infrastructure to provide high throughput sample management and analysis for DNA, RNA and protein-based technologies to hundreds of labs globally. His methodologies focus on extending the use of valuable samples by extracting and renewing limited quantities of biomaterial with newly developed technologies.

Dr. Brooks is a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. These studies investigate gene-environment interactions in the context of aging, neurodegenerative disease and neurotoxicant exposure. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for nucleic acid and protein analyses

Dr. Brooks is the Director of the Bionomics Research and Technology Center (BRTC) at the Environmental and Occupational Health Science Institute of the University of Medicine and Dentistry of New Jersey. He is an Associate Professor of Environmental Medicine and Genetics at UMDNJ/Rutgers. He received his Ph.D. from the University of Rochester, School of Medicine.

lindaB

Linda Brzustowicz

Director of Phenotypic Quality Control

As Director of Phenotypic Quality Control, Dr. Linda Brzustowicz is responsible for oversight of procedures related to the deposition and review of those phenotypes maintained by the RUCDR. Additionally, Dr. Brzustowicz conducts internal research projects focusing

Click to read more or click to close

on detailed phenotypic analyses. Dr. Brzustowicz has had an active research program in psychiatric genetics for over twenty years, with a focus on schizophrenia and autism. Her work includes development of phenotype definitions, subject recruitment and assessment, genotyping and statistical analysis for linkage and association studies, comparative genomic analysis, and gene expression studies.

At Rutgers University, Dr. Brzustowicz runs the Psychiatric Genetics Laboratory, is the Chair of the Department of Genetics, and is Acting Senior Associate Vice President for Research and Economic Development. She has a bachelor’s degree from Harvard University, an M.D. degree from Columbia University, completed residency training in psychiatry at Columbia University, and is ABPN certified in psychiatry.

   frahm2

Stephanie Frahm

Director of Laboratory Services Management and Operations

As Director of Laboratory Services Management and Operations, Stephanie Frahm is responsible for supervision of all aspects of the Nucleic Acid Services Laboratory, including development

Click to read more or click to close

and optimization of complex laboratory processes and project management infrastructure.  Leveraging a background in genomic technologies, laboratory automation, and project management, Stephanie translates client needs into efficiently executed laboratory programs that produce high quality biomaterial and data deliverables.  Specifically, she oversees BioProcessing Solutions Alliance projects with focus on ensuring all laboratory services are launched and executed consistently across locations globally and on building customized laboratory service programs for clients.

Stephanie received a Bachelor of Science degree in Biology from Temple University and a Master of Science degree in Molecular Genetics from Rutgers University.

danaWitt

Dana Garbolino

Director of Communications

As Director of Communications, Dana Garbolino oversees daily operations of the Communications unit whose primary responsibilities include accessioning biomaterials and the administrative duties required to service a robust client portfolio.

Click to read more or click to close

She is involved in the integration of new and ongoing projects in respect to the services provided to the global research community. Dana also takes a lead role in the administrative processing of distributions in order to ensure the timely delivery of research biomaterials.

Dana possesses a substantial depth of experience with RUCDR Infinite Biologics. She joined in 2004 and has witnessed the exponential growth of the organization. During this time, Dana has been elemental in fostering solutions for a wide range of client needs, including the transition from manual data dictation to a fully integrated electronic platform, recognizing and developing solutions in respect to reporting on the progress of biomaterials processing, and the intensive coordination among various units to function holistically as it regards records. She also held positions as a managing client coordinator for Prostaff and an IT recruiter for DMR Consulting.

liang2

Li Liang

Director of Clinical Genomics Laboratory

As Director of the Clinical Genomics Laboratory, Dr. Li Liang is responsible for operational aspects of the CLIA laboratories, including ensuring compliance with all applicable clinical laboratory regulations.  The laboratory performs a wide variety of molecular genetic tests on

Click to read more or click to close

patients and Dr. Liang reviews, interprets and reports on all laboratory results.

Dr. Liang has more than 20 years of experience in research of DNA damage repair, animal models to kidney stone disease and impact of genetic variants on congenital heart disease and alcoholism.  He is board certified in Clinical Molecular Genetics and Cytogenetics by the American Board of Medical Genetics and is a fellow of the American College of Medical Genetics.  Dr. Liang received his Ph.D. degree in Molecular and Medical Genetics from Indiana University School of Medicine. 

janetMcKim

Janet McKim

Director of Development

As Director of Development, Janet McKim is responsible for branding and commercialization of services, developing tools for initiating and tracking business opportunities in the public and private sector, developing and implementing

Click to read more or click to close

strategies to increase core business exposure, and creating marketing and technical materials for service offerings. She manages company alliances and participation at trade shows, conferences, and market events.

Janet has 15 years of experience in facility management and expansion. She is knowledgeable in the areas of grant writing, journal publication, microscopy, and scientific training. As a board member with a non-profit organization, she initiated and managed program development, community outreach, special events, and annual fundraising. She has numerous scientific publications which include high profile journals such as Nature and Science. Her work has been featured on the cover of journals and methodology books. She is also Director of Development for the Human Genetics Institute of New Jersey. Janet graduated with honors with a bachelor’s degree from the University of California.

jenmoore-1

Jennifer Moore

Associate Director of the Stem Cell Laboratory

As Associate Director of the Stem Cell Laboratory, Dr. Jennifer Moore is responsible for the generation, expansion and banking of induced pluripotent stem cells (iPSC) and the characterization of these cells.

Click to read more or click to close

Dr. Moore has more than 12 years' experience working with pluripotent stem cells and under her guidance the Stem Cell Laboratory creates and standardizes protocols for deriving iPSC from many different types of source cells, continuously adopts the latest technologies for deriving "foot-print-free" iPSC (iPSC that have no integration of exogenous sequences into their genomes), and develops protocols for the differentiation of iPSC into different lineages.  She also oversees the isolation and expansion of fibroblasts and other cell types to be used as source cells for iPSC.  Dr. Moore received her Bachelor of Science degree in Chemistry for the University of North Carolina at Chapel Hill and her Ph.D. in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill.

 

mikeM

 Michael Moreau

Associate Director of Analytical and Informatics Services

As the Associate Director of Analytical and Informatics Services, Dr. Michael Moreau is responsible for developing and implementing methodologies for high-throughput genetic analysis. He maintains high level oversight

Click to read more or click to close

through management of technical laboratory operations and ensures quality output. 

Dr. Moreau continuously serves both academic and industry clients by spearheading Genomics initiatives to expand service offerings.  Dr. Moreau has an extensive technical and computational background.  His expertise was instrumental in establishing the Next-Generation Sequencing program and the associated bioinformatics pipelines at RUCDR and in streamlining and automating gene expression and genotyping workflows.  Dr. Moreau received his Bachelor of Arts in Genetics and Microbiology and his Ph.D. in Microbiology and Molecular Genetics from Rutgers, The State University of New Jersey.

navnit

Navnit Patel

Director of Quality Assurance

As Director of Quality Assurance, Dr. Navnit Patel is responsible for ensuring all RUCDR departments and employees are aware of, and follow compliance guidelines as outlined by various federal gencies, industry standards and customer requirements.

Click to read more or click to close

He develops and executes strategies that drive implementation and continuous improvements of a robust quality system at RUCDR.

Dr. Patel has over 20 years of experience working with global leaders of the Pharmaceuticals industry such as Merck, Bristol Myer Squibb, Schering Plough, McNeil (J & J) and Novartis, where he held various leadership positions in quality departments. Dr. Patel is a certified Black-belt, mentor and facilitator for Lean Six Sigma. Along with proven performance in the quality arena, Dr. Patel has a strong educational and technical background.  He holds a Ph.D. in Organic Chemistry with over 20 research publications in internationally recognized journals.

mituPati

Sanghamitra Pati

Director of Finance

As Director of Finance, Mitu Pati is responsible for all aspects of finance and accounting, including diverse operational areas such as grant and contract reporting and human resources.

Click to read more or click to close

She has over sixteen years of experience in overseeing financial aspects of major government grants, contracts, and cooperative agreements.

Mitu joined RUCDR Infinite Biologics in 2009. Prior to that time, she was the Director of Finance at the Indiana University School of Health and Rehabilitation Sciences where she was responsible for the overall financial and grant activities such as pre-award and post-award administration of the school. She also worked as Business Manager at the Indiana University School of Medicine, School of Allied Health and as internal auditor at Indiana University and University of Wisconsin. Her expertise includes working on Oracle/PeopleSoft and other legacy systems. Mitu received a bachelor’s degree in Accounting and an MBA from the University of Wisconsin. She also holds a Master’s degree from India.

amrikSahota

Amrik Sahota

Director of Scientific Programs

As Director of Scientific Programs, Dr. Amrik Sahota is responsible for educational and training programs for technical staff, accreditation and certification of RUCDR by regulatory agencies, molecular diagnostic testing of

Click to read more or click to close

genetic diseases for research purposes, and verification of pedigree relationships and resolution of cell line or DNA quality control issues.

Dr. Sahota is highly experienced in the development and implementation of molecular diagnostic assays for genetic, hematologic, and infectious diseases. He’s actively involved in research on the molecular pathology of inherited urinary tract stone disease. Dr. Sahota is also laboratory director for molecular pathology in the Department of Pathology and Laboratory Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School (UMDNJ-RWJMS).

He is board certified in Clinical Molecular Genetics by the American Board of Medical Genetics and in Molecular Diagnostics by the American Board of Clinical Chemistry. He is a fellow of the Academy of Clinical Biochemistry, American College of Medical Genetics, Institute of Biology (UK), and the Royal College of Pathologists (UK). Dr. Sahota has a PhD in medical genetics from Guy’s Hospital Medical School, University of London (UK).

jackSchrum

Jack Schrum

Director of Facilities and Logistics

As Director of Facilities and Logistics, Jack Schrum manages the daily non-technical operations of the RUCDR. He is responsible for the purchasing of all equipment and supplies and the maintenance of appropriate supply

Click to read more or click to close

levels both on-site and off-site at the RUCDR warehouse, which is accessed via the RUCDR owned truck. Jack supervises the support staff responsible for supply procurement and distribution, human resource management, and sample collection kit assembly and distribution.

Jack has been at RUCDR since 2000 and at Rutgers University for 16 years. He graduated with a bachelor’s from Rutgers College.

mikeSheldon

Michael H. Sheldon

Director of Stem Cell Laboratories

As Director of the Stem Cell Laboratories, Dr. Michael Sheldon is responsible for all operational aspects of the laboratories, including sample processing and project management. The laboratories perform a wide

Click to read more or click to close

variety of services related to stem cell research, including the cultivation of source cells from tissue biopsies, induced Pluripotent Stem Cell (iPSC) reprogramming, and quality control. Dr. Sheldon also manages a number of projects, including the Simons Foundation for Autism Research Initiative (SFARI), Autism Speaks, the Immune Tolerance Network and TrialNet (NIAID).

Dr. Sheldon has more than 20 years of experience in the study of the biochemistry of transcriptional regulation and the molecular mechanisms governing the development of the mammalian brain. Prior to his current position, while at the St Jude Children’s Research Hospital, he discovered a signal transduction adapter gene, disabled-1 that is essential for reelin-mediated signaling of neuronal migration in the developing mammalian brain. Dr. Sheldon is currently interested in using stem cells to aid in elucidating the role of neurodevelopmental defects in a variety of human disorders, with particular emphasis on autism. He received his Bachelor of Arts degree from Cornell University and a Ph.D. in Genetics from SUNY at Stony Brook.

linkedintwitterFacebook

145 Bevier Road Piscataway NJ 08854-8009
p 732 445 1498 f 732 445 1149 www.rucdr.org